Glycemic control and preventive care measures of indigent diabetes patients within a pharmacist-managed insulin titration program vs standard care;El Control Glicémico y las Medidas Para el Cuidado Preventivo de Pacientes Diabéticos Indigentes Dentro de un Programa de Titulación de Insulina Manejado por un Farmacéutico vs el Cuidado Estándar

Annals of Pharmacotherapy

Volumn 46, Issue 1, 2012, Pages 29-34

  Salvo, Marissa C ^a,b   Brooks, Amie McCord ^a  

^a Division of Pharmacy Practice   (Canada)

^b UNIVERSITY OF CONNECTICUT   (United States)

Author keywords

Diabetes preventive care; Glycemic control; Indigent population; Insulin titration; Pharmacist managed care

Indexed keywords

GLUCOSE; HEMOGLOBIN A1C; INFLUENZA VACCINE; INSULIN; ORAL ANTIDIABETIC AGENT; PNEUMOCOCCUS VACCINE;

ADULT; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; DIABETES MELLITUS; DIABETIC PATIENT; DRUG DOSE TITRATION; EYE EXAMINATION; FEMALE; FOOT CARE; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HUMAN; INDIGENT; INSULIN TREATMENT; INTERMETHOD COMPARISON; LOWEST INCOME GROUP; MAJOR CLINICAL STUDY; MALE; MEDICAL CARE; MEDICAL EXAMINATION; MICROALBUMINURIA; PHARMACIST; PHARMACIST MANAGED CARE; PREVENTIVE MEDICINE; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SCREENING; STANDARD; TELEMEDICINE; TREATMENT OUTCOME; WEIGHT CHANGE;

EID: 84855675672     PISSN: 10600280     EISSN: None     Source Type: Journal    
DOI: 10.1345/aph.1Q512     Document Type: Article

References (20)

1. National diabetes fact sheet: national estimates and general information on diabetes and prediabetes in the United States. http://www.cdc.gov/diabetes/pubs/factsheet11.htm (accessed 2011 Feb 5).
2. Mann DM, Ponieman D, Leventhal H, Halm EA. Misconceptions about diabetes and its management among low-income minorities with diabetes. Diabetes Care 2009;32:591-3. DOI 10.2337/dc08-1837
3. American Diabetes Association. ADA clinical practice recommendations. Standards of medical care in diabetes-2011. Diabetes Care 2011;34(suppl):S11-61. DOI 10.2337/dc11-S011
4. Kiel PJ, McCord AD. Pharmacist impact on clinical outcomes in a diabetes disease management program via collaborative practice. Ann Pharmacother 2005;39:1828-32. DOI 10.1345/aph.1G356
5. Schectman JM, Nadkarni MM, Voss JD. The association between diabetes metabolic control and drug adherence in an indigent population. Diabetes Care 2002;25:1015-21. DOI 10.2337/diacare.25.6.1015
6. McCord AD. Clinical impact of a pharmacist-managed diabetes mellitus drug therapy management service. Pharmacotherapy 2006;26:248-53. DOI 10.1592/phco.26.2.248
7. Chock A, Destahe C, Herrmann J, Stading J, Waiters R. Impact of a pharmacist intervention on diabetes patients in an ambulatory setting. Diabetes Spectrum 2009;22:241-6.
8. Ramser K, Sprabery L, George C, et al. Physician-pharmacist collaboration in the management of patients with diabetes resistant to usual care. Diabetes Spectrum 2008;21:209-13.
9. Rochester C, Leon N, Dombrowski R, Haines S. Collaborative drug therapy management for initiating and adjusting insulin therapy in patients with type 2 diabetes mellitus. Am J Health Syst Pharm 2010;67:42-8. DOI 10.2146/ajhp080706
10. Irons BK, Seifert CF, Horton NA. Quality of care of a pharmacist managed diabetes service compared to usual care in an indigent clinic. Diabetes Technol Ther 2008;10:220-6. DOI 10.1089/dia.2007.0262
11. Riddle MC, Rosenstock J, Gerich J. The Treat-to-Target Trial: randomized addition of glargine or human NPH insulin to oral therapy of type 2 diabetic patients. Diabetes Care 2003;26:3080-6. DOI 10.2337/diacare.26.11.3080
12. Resnick H, Bardsley J, Foster G, Ratner R. Achievement of American Diabetes Association Clinical Practice Recommendations among US adults with diabetes, 1999-2002: the National Health and Nutrition Examination Survey. Diabetes Care 2006;29:531-7. DOI 10.2337/diacare.29.03.06.dc05-125
13. Sequist T, Fitzmaurice G, Marshall R, et al. Physician performance and racial disparities in diabetes mellitus care. Arch Intern Med 2008;168:1145-51.
14. American Diabetes Association: Standards of Medical Care 2010. Diabetes Care 2010;33(suppl):S11-61. DOI 10.2337/dc10-S011
15. Glazier R, Bajcar J, Kennie N, et al. A systematic review of interventions to improve diabetes care in socially disadvantaged populations. Diabetes Care 2006;26:1675-88. DOI 10.2337/dc05-1942
16. The California Medi-Cal Type 2 Diabetes Study Group. Closing the gap: effect of diabetes case management on glycemic control among low-income ethnic minority populations. Diabetes Care 2004;27:95-103.
17. United Kingdom Prospective Diabetes Study Group. Effect of intensive blood glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). Lancet 1998;352:854-66.
18. Stratton IM, Adler AI, Neil AW, et al. Association of glycaemia with macrovascular and microvascular complications in type 2 diabetes (UKPDS 35): prospective observational study. BMJ 2000;321:405-12. DOI 10.1136/bmj.321.7258.405
19. Wagner EH, Sandu N, Newton KM, et al. Effect of improved glycemic control on health care costs and utilization. JAMA 2001;285:182-9. DOI 10.1001/jama.285.2.182
20. Gerber R, Liu G, McCombs J. Impact of pharmacist consultations provided to patients with diabetes on healthcare costs in a health maintenance organization. Am J Manag Care 1998;4:991-1000.